Increlex Related Published Studies
Research related to Increlex (Mecasermin Injection)
Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX. [2008.03]
Mecasermin. [2008]
Mecasermin rinfabate. [2007.03]
Mecasermin Tercica. [2006.04]
Other possibly related research studies
New drugs 07, part I. [2007.02]
Serum levels of insulin-like growth factor-I, IGF-binding protein 1 and 3, and insulin and endometrial cancer risk. [2003.11.03]
Glucocorticoid antagonist RU38486 fails to block acid-induced muscle wasting in vivo or in vitro. [2003.08]
[Growth hormone, insulin-like growth factor and insulin-like growth factor binding protein in young type I diabetes patients with the onset of diabetic angiopathy] [2003.04]
Serum insulin-like growth factor levels do not predict functional recovery after hospitalization in nonagenarian patients. [2003]
GH values after clonidine stimulation measured by immunofluorometric assay in normal prepubertal children and GH-deficient patients. [2003]
The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarism. [2003.05]
Recombinant human growth hormone therapy in autosomal recessive polycystic kidney disease. [2003.01]
Expression of V-1, a novel catecholamine biosynthesis regulatory protein, is enhanced by hypertension in atrial myocytes of Dahl salt-sensitive rats. [2002.11.15]
Systemically administered mesenchymal stromal cells transduced with insulin-like growth factor-I localize to a fracture site and potentiate healing. [2002.10]
How can physicians and their patients with ALS decide to use the newly-available treatments to slow disease progression? [1999.12]
Therapeutic potential of insulin-like growth factor-1 in patients with diabetes mellitus. [2002]
The role of recombinant insulin-like growth factor I in the treatment of the short child. [2007.08]
Anaphylactic reaction to recombinant insulin-like growth factor-I. [2008.04]
Insulin-like growth factor-I deficiency in children with growth hormone insensitivity: current and future treatment options. [2009]
miR-375 enhances palmitate-induced lipoapoptosis in insulin-secreting NIT-1 cells by repressing myotrophin (V1) protein expression. [2010.01.25]
Insulin-like growth factor I and insulin and their abuse in sport. [2010.03]
Recombinant human insulin-like growth factor-I therapy for children with growth disorders. [2008.12]
Inner ear drug delivery system from the clinical point of view. [2010.11]
Inhibition of nuclear factor kappaB regresses cardiac hypertrophy by modulating the expression of extracellular matrix and adhesion molecules. [2011.01.01]
|
